SERVIER - Key Persons
Job Titles:
- Executive Vice President / Corporate Strategy & Transformation
Charlotte Marmousez-Tartar has over 15 years' experience in the pharmaceutical industry in France and Singapore. She began her career at Servier in 2006, as Global Competitive Project Manager, where her duties included marketing and strategic intelligence. She then joined Servier's Singapore subsidiary in 2011, where she held operational positions on the marketing and sales teams.
In 2015, Charlotte Marmousez-Tartar was appointed Strategic Forecasting Director, in charge of R&D and business development projects and steering the 10-year strategic plan. She then joined the Corporate Strategy Department in 2017, where she successively held the positions of Strategic Projects Director, then Corporate Strategic Planning Director. In 2021, Charlotte Marmousez-Tartar was appointed Head of Group Transformation & Programs Office. Since 2019, she has also been Secretary of the Servier Group Executive Committee.
In February 2024, Charlotte Marmousez-Tartar became Executive Vice President Corporate Strategy & Transformation. She is particularly responsible for steering the Group's global strategy and coordinates all its transformation projects. In addition, she is a member of the Liaison Committee, whose role is to assist the Supervisory Board in fulfilling its mission of monitoring the Servier Group's independence and sustainability.
Charlotte Marmousez-Tartar holds a doctorate in pharmacy from the Université de Lille 2 Sciences et Technologie. She also holds a master's degree in marketing Intelligence from HEC Paris.
Christian Wyss joined Servier's Supervisory Board in October 2022.
Christian Wyss is a corporate attorney with a deep understanding of the Life Sciences industry having assisted numerous start-ups and pharma companies.
He is a partner at the Swiss law firm VISCHER with offices in Zurich, Basel and Geneva and co-heads the Corporate Team, the largest team of the firm.
Christian Wyss frequently represented parties in complex transactions and has acted as team leader in more than 10 major industry collaborations, five M&A transactions and 23 financing transactions in the life sciences industry.
Christian Wyss holds an LL.M.. from Wake Forest University School of Law and a law degree (lic. iur.) from the University of Basel. He has studied as well at the Université de Lausanne.
Damien Catoir - Chief Legal Officer, EVP, Secretary
Job Titles:
- Corporate Secretary
- Executive Vice President
- General Counsel
- Executive Vice President General Counsel and Corporate Secretary
- Member of the New York
Damien Catoir came aboard the Servier Group in April 2023, as Executive Vice President General Counsel and Corporate Secretary. He is a member of the Group Executive Committee.
Damien Catoir has more than 15 years of experience in banking and in major law firms, both in France and in the United States. He joined the corporate world in 2018 within the ATOS Group, where he was General Counsel and Secretary to the Board of Directors.
As part of his missions, he guided ATOS in the negotiation of strategic partnerships major contracts and significant M&A transactions. He also piloted complex litigations and important corporate reorganizations.
Damien Catoir is a member of the New York and Paris bars. He holds a Master in Management from ESSEC Business School and studied at the École Normale Supérieure. He also holds a Master's degree in General Private Law from the University of Paris 1 Panthéon-Sorbonne, and a Juris Doctor degree from Cornell Law School in the United States.
Job Titles:
- Executive Vice President Human Resources
David Hindley joined the Servier Group as of March 1, 2023, in the role of Executive Vice President Human Resources, and member of the Group Executive Committee.
David Hindley has over 20 years of experience in various sectors within multinational companies such as Total Energies, Areva, Axa, Danone and most recently at Mars Wrigley.
Passionate about talent development, he has created and deployed various tools and methodologies to enable employee growth. David Hindley also led major transformation programs through multiple experiences, including the evolution and deployment of leadership models.
David Hindley received his degree in Human Resources Management from CIFFOP (Interdisciplinary Center for Human Resources Education) at the University of Paris-Panthéon-Assas in 1999. He also holds a post-graduate degree in Organizational Psychology and three certificates in Employment Law, Compensation & Benefits and Coaching.
Job Titles:
- Member of the Supervisory Board and Chair of Audit Committee of H. Lundbeck a / S
- Professional Board Member
Dorothea Wenzel has been a member the Supervisory Board of Servier since October 2023. She chairs the Servier's Audit Committee.
She is an accomplished finance, business and operations professional spanning diverse business' settings, cultures, locations and modalities in the life sciences sector.
Dorothea Wenzel is currently a professional Board member.
She had a long career at Merck KGaA, headquartered in Darmstadt, Germany, where she most recently until August 2021 served as Executive Vice President and Head of the Global Business Unit Surface Solutions. In 2018 she was the CFO & Head of Strategy of the Performance Materials Division, from 2014 to 2018 she headed Merck's Global Fertility Business Franchise, and from 2005 to 2013 she was the CFO of Merck's Healthcare division. Prior to Merck she worked at McKinsey & Comp., with an e-commerce startup and for a German governmental commission.
Dorothea Wenzel is also a member of the Supervisory Board and Chair of Audit Committee of H. Lundbeck A/S and a member of the Board of Directors of Dentsply Sirona Inc..
Dorothea Wenzel holds a PhD in Health Economics & Macroeconomics and a M.Sc. in Business & Computer Sciences from the University of Darmstadt in Germany. She has also held fellowships at Harvard and was a visiting student at the University of California at Berkley.
Job Titles:
- Executive Vice President
- Executive Vice President Global Medical & Patient Affairs
- Medical Doctor and Cardiologist
Over the past 25 years at Servier, Arnaud Lallouette has built a diverse and successful career within the Group, by capitalizing on several senior positions (Head of Medical Affairs and General Manager), but also by being exposed to a range of markets and disciplines.
Working and living in France, Denmark, Sweden, Finland, the UK, Australia, and Canada, and leading teams across three continents, has ultimately shaped his understanding of patients' needs and healthcare systems worldwide. It fueled his commitment to providing equitable access to care for patients.
Today, passionate and driven by People, Life Sciences, and Performance, Arnaud Lallouette has further strengthened his commitment to Environment, Social, and Governance (ESG) principles, to create the greatest long-term value for patients and people.
Arnaud Lallouette is a medical doctor and cardiologist who graduated from Nancy 2 University in France.
Job Titles:
- Executive Vice President Research and Development, Chief Scientific Officer
With over 25 years' experience in research and development and international operations within a number of leading pharmaceutical groups (Novartis, Roche, Pfizer, AstraZeneca and Ipsen), Claude Bertrand joined Servier in 2017 as Executive Director R&D and Chief Scientific Officer.
In 2018, he was appointed to the Group's Executive Committee and the role of Executive Vice President Research and Development.
Claude Bertrand also sits on the boards of directors of Eclosion2 and MAAT Pharma. He is President of the scientific committee of LabEx Medalis and Vice President of MEDICEN.
After graduating as a Doctor of Pharmacy from the University of Strasbourg, he completed a PhD and continued onto postdoctoral studies at the University of California, San Francisco, conducting research in immunopharmacology and neurogenic inflammation.
Job Titles:
- Executive Vice President
- Cardiologist
- Executive Vice President Global Product Strategy
Philippe Gonnard began his career with the Servier Group in 1993 as International Product Manager, before becoming Marketing Manager France, Medical Affairs Director France and General Manager France. Having once headed a subsidiary, he was appointed Manager of the West Europe Zone, then subsequently Head of World Operations Oncology.
In 2016, Philippe Gonnard was made head of Global Medical Affairs. In his capacity as Executive Vice President Global Medical & Patient Affairs, he has sat on the Servier Group Executive Committee since 2018. Between 2020 and 2022, Philippe Gonnard was also Chief Medical Officer of the Servier Group. In 2023, Philippe Gonnard becomes Executive Vice President Global Product Strategy.
Philippe Gonnard is a cardiologist and holds an MBA from HEC Paris.
Job Titles:
- Deputy Vice President of Industrial Operations
- Executive Vice President Manufacturing, Quality and Supply Chain
Hani Friedman Bouganim has over 17 years' international experience with a proven track record of achieving strategic, financial and operational goals in the pharmaceutical sector across all stages of a product's life cycle.
From 2007 to 2022, Hani Friedman Bouganim held various pivotal roles at Teva, a multinational pharmaceutical company. Notably, she served as Vice President of Operations and Managing Director of Ulm & Weiler sites in Teva Germany from 2021 to 2022. Prior to that, she acted as Cluster Lead for three pharmaceutical sites in Krakow/Poland, Troyan/Bulgaria, and Baldoyle/Ireland. She held different positions such as Site General Manager in Krakow, Poland, and Ashdod & Kiryat Shmona sites in Israel and was President of the Board for Teva Operations Poland from 2018 to 2021. Her experience also includes Senior Director positions at Teva, where she headed Respiratory Operations in Jerusalem from 2015 to 2017 and led Manufacturing, Science, and Technology for Oral Solid Dosages and Multidose Dry Powder Inhaler sites from 2011 to 2015.
In November 2022, Hani Friedman Bouganim joined Servier as Deputy Vice President of Industrial Operations. In April 2024, she was appointed Executive Vice President to oversee the Manufacturing, Quality, and Supply Chain activities and joined the Servier Executive Committee. In her new position, she will drive transformation and innovation in line with the Servier 2030 ambition.
Hani Friedman Bouganim holds a Master of Business Administration (MBA) from Ben-Gurion University, Israel, and a Bachelor of Science (BSc) in Biotechnology Engineering.
Jean-Christophe Tellier joined Servier's Supervisory Board in March 2022.
Jean-Christophe Tellier is an experienced global leader with a patient-centric and sustainability approach, a passion for science, combined with strategic and operational skills.
He acts since 2015 as UCB's Chief Executive Officer after having successfully led UCB's BioBrands and Solutions division as Executive Vice President.
Jean-Christophe Tellier has built a distinguished 30+-year career in the biopharmaceutical industry, taking on different global leadership responsibilities in different parts of the world.
He is a member of the Board of Directors of UCB, member of BCR (Biopharmaceutical CEOs Roundtable); member of the Board of the European Federation of Pharmaceutical Industries and Associations (EFPIA). He is also a member of the Board of PhRMA (Pharmaceutical Research and Manufacturers of America).
Jean-Christophe Tellier was trained as a Medical Doctor and specialized in rheumatology.
Job Titles:
- Chairman of the LAVA Therapeutics
- Medical Oncologist
- Professional Board Member
Kapil Dhingra joined Servier's Supervisory Board in March 2022.
Dr. Dhingra is a medical oncologist and a physician-scientist with a proven track record in academic research, patient care and drug development.
Kapil Dhingra is currently a professional Board member.
He served as vice president, head of the oncology disease biology leadership team and head of oncology clinical development at Roche, during which he led numerous drug approvals, including Herceptin®, Tarceva® and Avastin®. Prior to joining Roche, he worked in the oncology clinical development group at Eli Lilly. Dr. Dhingra has served as a faculty member at The University of Texas M.D. Anderson Cancer Center, Indiana University School of Medicine and Memorial Sloan Kettering Cancer Center.
Dr. Dhingra is currently chair of the LAVA Therapeutics and also a member of the boards of Black Diamond Therapeutics, Replimune, Median Technologies, Mariana Oncology as well as Kirilys Therapeutics.
Dr. Dhingra obtained his bachelor of medicine-bachelor of surgery degree (M.B.B.S.) from the All India Institute of Medical Sciences in New Delhi, India. He completed his residency in internal medicine at Lincoln Medical and Mental Health Center, New York Medical College and completed his fellowship in hematology and oncology at Emory University School of Medicine in Atlanta.
Job Titles:
- President of the Supervisory Board
Job Titles:
- President
- President and CEO of the Servier Group and the Servier International Foundation for Research
A graduate of the Panthéon-Assas University in Paris, France, Olivier Laureau joined the Servier Group in 1982 in the Intellectual Property Department before joining the Legal Department where he oversaw international contracts. In 2000, he joined the Finance Department and was appointed Chief Financial Officer of the Group in 2008.
As President and CEO of the Group since 2014, Olivier Laureau has undertaken a holistic transformation plan to ensure its independence, development and sustainability and fulfil its vocation: committed to therapeutic progress to serve patient needs.
Olivier Laureau
President and CEO of the Servier Group and the Servier International Foundation for Research-
Job Titles:
- Executive Vice President
- Executive Vice President Generic Activities
Having studied pharmacy, Pascal Brière started his career in Belgium in a major French pharmaceutical group before he set up Qualimed, one of the first generic medicine laboratories in France.
After joining the Servier Group in 1996, he set up Biogaran to further expand the availability of generic medicines in France and became President of the laboratory.
Job Titles:
- Executive Vice President
- Finance
Pascal Lemaire boasts over 25 years' international experience in corporate finance, especially in retail and the pharmaceutical industry. Pascal Lemaire began his career outside France at Nestlé, where he spent 17 years in a variety of positions of responsibility across all areas of corporate finance and Global Business Services. In 2015, he was appointed Executive Director Finance & Business Planning at Celgene, a role in which he was responsible for all operations outside the US.
He joined Servier and the Group Executive Committee as Executive Vice President Finance in 2020.
Pascal Lemaire earned a degree in business studies and a Master's in Banking and Finance from HEC Lausanne.
Steven Baert joined Servier's Supervisory Board in February 2024.
He gets credited for building strong executive teams and fit-for purpose organizations. He is also seen as a trendsetter in leadership and talent development, the future of work and culture change.
Steven Baert joined GE Vernova in April 2023 as the Chief People Officer and member of the Executive Team.
He previously worked as managing partner and advisor on human capital to Private Equity and Venture Capital clients. He previously served as Chief People Officer and Member of the Executive Committee of Novartis from 2014 until June 2021. Before this, Steven served as Global Head, Human Resources, Novartis Oncology. Prior to joining Novartis, Steven held senior HR positions at Bristol- Myers Squibb Co. and Unilever.
Steven Baert also serves on the Board of Pharming Group and on the Board of WeSeeHope USA, a charity that focuses on empowering children isolated by poverty in Africa.
Steven Baert holds a Master of Business Administration from the Vlerick Business School, Gent; a Master of Laws from the Katholieke Universiteit Leuven and a Bachelor of Laws from the Katholieke Universiteit Brussels.
Job Titles:
- Executive Vice President
- Appointed Executive Vice President
- Executive Vice President World Operations
Stephane Mascarau started his career within the Servier Group in 1999.
Stephane Mascarau has a strong international background and brings with him over 20 years of pharmaceutical experience in marketing, sales and management. After having held different management positions within the marketing and sales teams, he became General Manager Mexico in 2008, General Manager Egypt in 2012 and General Manager Spain in 2015.
In 2017, he was appointed as General Manager China. In 2022, he became Zone Director Greater Chinese Area (China Mainland, Taiwan, Hong Kong, Macau) and Australia.
In the different countries, as well as the launches of new products in domains as varied as cardio-metabolism, venous diseases and oncology fields, he knew how to accompany and get the commitment of his teams in the transformation process and for the service of Performance he gave an important place to Digital activities.
As of January 2023, Stephane Mascarau is appointed Executive Vice President, World Operations, and a member of the Executive Committee of the Servier Group.
Stephane Mascarau holds a degree in Pharmacy at the University of Mediterranee (Aix-Marseille II), Marseille France and a Master degree in Pharmaceutical Marketing and Management at the University of Paris-Sud (Paris XI), France.
Job Titles:
- Executive Vice President
- Executive Vice President Digital, Data and Information Systems
- in 2020 As Chief Digital Officer
Virginie Dominguez joined Servier in 2020 as Chief Digital Officer, before she was appointed to the Executive Committee in 2021 as Executive Vice President Digital, Data and Information Systems. She has been tasked with implementing and steering the digital transformation at Servier to enable the Group to become a Digital Performer by 2025.
Virginie Dominguez boasts 20 years' experience in digital technology, primarily in the Orange group where she held various positions of responsibility between 2003 and 2019. In particular, while at Orange France, she brought about the digital transformation of retail customer relations and oversaw a vast "widespread agility" transformation program involving several thousand employees.
Virginie Dominguez graduated from the École polytechnique, France, and earned a degree in engineering from the École Ponts et Chaussées.